Treatment Resistant Depression Flashcards
Failure to respond to two or more antidepressants from different classes with adequate does, duration and compliance is?
TRD Treatment resistant depression
Response that falls short of remission is associated with what 5 things?
Higher relapse Poorer work productivity Impaired psychosocial fxn Higher levels of health care use Higher risk for suicide
Subtherapeutic doses of antidepressants, patient nonadherence, intolerable side effects, and wrong diagnosis are a number of conditions for the possible causes of what?
Relative or “pseudo” TRD
Of all the factors associated with TRD, what two are the most prominent?
Anxiety and panic disorders
This study’s primary goal was to see what drug or combination of drugs would lead to the highest percent of remission?
STAR*D
Was there a placebo group in the STAR*D trial?
No, patients were given the choice between augmentation of meds and switching meds
For level 1 of the STAR*D trial, all patients were started on what med and dose?
What is the max dose of that SSRI?
Citalopram (Celexa), 20mg
40mg
For level 2 of the STAR*D trial patients could either switch to _______, ______ ______, ________, or ________. Or they could augment the citalopram (Celexa) with either ______, _______, or ________.
Switch: Bupropion (Wellbutrin), cognitive therapy, sertraline (Zoloft), venlafaxine (Effexor)
Augment: Buproprion (Wellbutrin) same as above but added on, buspirone (anxiolytic), cognitive therapy (same as above)
Level 3 of STAR*D trial says to switch to ____ or ____, and to augment with ____ , _____, ____, and _____.
Level 3 Switch to mirtazipine (remeron) or nortriptyline
Level 3 augment w/ lithium, triiodothyronine, (only with bupropion, sertraline, venlafaxine)
Patients had a _____% response rate to level 1 celexa, but only 1/3 of those completely remissed.
47% response to celexa alone in level 1
What is the best predictor of whether or not a patient will respond to an ADM?
Early response
What categories of patients had higher remission rates (were cured)?
Female White Employed Higher levels of education Insured Shorter current episode Fewer concurrent medical or psych disorders
What patients required more treatments in the STAR*D trial?
Those who were more severely depressed
More concurrent psych and med disorders
Concurrent anxiety
If level 1 citalopram (celexa) doesn’t provide complete remission, level 2 additions of Bupropion, sertraline, and venlafaxine are provided and celexa is discontinued (switch, not augment). What were the results?
All of the new meds had about a 25% remission for the L-2 switch from celexa
For the L-2 augmentation with Bupropion or Buspirone addition, remission rates did what?
Bupropion jumped to 39% remission, and Buspirone to 32.90%, a markedly higher percent than the L-2 switch (25%)